Does insurance cover prostate embolization?

Sometimes, with conditions that can be narrow. Five of the 10 insurers we checked in November 2026 have written policies that cover prostate artery embolization (PAE). Medicare has no specific policy and decides case by case. Three others have no written policy we could find, and Kaiser's Washington region does not cover it. Your plan may differ.

Your plan may differ. Employer self-funded plans and Medicare Advantage plans can set their own rules. Check with your plan.

Education, not medical advice. Talk to your doctor about your own care. We cannot advise you on your own claim or prior authorization.

See every insurer

Medicare (Original)

Decided case by caseNo specific Medicare policy; decided case by case.

No national or local Medicare document we found names this procedure in its title. Each Medicare contractor decides, case by case, whether it is reasonable and necessary, under a general 1978 decision on embolization.

Decided case by case: No Medicare document we found names this procedure in its title. Each case gets its own decision.

Checked November 7, 2026 · Medicare national decision 20.28, Therapeutic Embolization · Dated December 15, 1978

UnitedHealthcare

Covered with conditionsEither of two routes.

All other uses are not covered.

  • Lasting visible blood in the urine that comes from the prostate
  • Enlarged prostate symptoms confirmed by a board-certified urologist, after medicines (an alpha-blocker, a 5-alpha reductase inhibitor, or both) have failed, plus one of: a serious other illness (ASA class III or higher), a bleeding disorder, being unable to stop blood thinners, or a prostate over 80 grams on imaging

Covered with conditions: The insurer's written policy covers it only when the listed conditions are met.

Checked November 7, 2026 · Prostate Surgeries and Interventions (2026T0618P) · In effect June 1, 2026

UnitedHealthcare Medicare Advantage

Covered with conditionsUses the same conditions as UnitedHealthcare's other plans.

All other uses are not covered.

  • Lasting visible blood in the urine that comes from the prostate
  • Enlarged prostate symptoms confirmed by a board-certified urologist, after medicines (an alpha-blocker, a 5-alpha reductase inhibitor, or both) have failed, plus one of: a serious other illness (ASA class III or higher), a bleeding disorder, being unable to stop blood thinners, or a prostate over 80 grams on imaging

Covered with conditions: The insurer's written policy covers it only when the listed conditions are met.

Checked November 8, 2026 · Prostate Services and Procedures and Impotence Treatment (MMP075.14) · In effect September 1, 2026

Anthem (Elevance)

Covered with conditionsOnly in two situations.

Based on the Carelon guideline that Anthem plans appear to use.

  • Moderate to severe enlarged prostate symptoms in a man who is not a candidate for surgery
  • Bleeding from the prostate

Covered with conditions: The insurer's written policy covers it only when the listed conditions are met.

Checked November 7, 2026 · Vascular Embolization and Occlusion Procedures, Carelon guideline CAR15-1126.1 · Effective November 15, 2026

Aetna

CoveredListed as medically necessary for an enlarged prostate, as an alternative to prostate surgery (TURP).

The policy statement lists no further conditions.

Covered: The written policy covers it and states no further conditions.

Checked November 7, 2026 · Clinical Policy Bulletin 0079, Benign Prostatic Hyperplasia · Last reviewed October 15, 2026

Aetna Medicare Advantage

Not yet checkedAetna says its Medicare Advantage plans can use their own criteria where Medicare's are not fully established.

It does not say which rules apply to this procedure, and we have not read them. Call your plan.

Not yet checked: We have not read this plan's rules for this procedure.

Checked November 8, 2026 · Aetna Medicare guidance on utilization management · Undated; Aetna labels it as of January 1, 2024

Cigna

Covered with conditionsEnlarged prostate with urinary symptoms, after medicines (an alpha-blocker or a 5-alpha reductase inhibitor) failed or could not be tolerated, plus one of these.

A repeat is allowed after a good first response if symptoms return after 6 months. Applies where EviCore manages the service for Cigna.

  • Blood in the urine from the prostate
  • Being unable to pass urine, to get off a catheter, when the bladder still works
  • Severe symptoms (a score of 20 or more on the AUA symptom questionnaire) with a prostate of 50 cc or more
  • Blockage from a protruding middle lobe
  • Not a candidate for surgery because of age, other illnesses, a bleeding disorder, or blood thinners

Covered with conditions: The insurer's written policy covers it only when the listed conditions are met.

Checked November 7, 2026 · Cigna Peripheral Vascular Intervention Guidelines (EviCore, V2.0.2026) · In effect November 5, 2026

Humana Medicare Advantage

Covered with conditionsEither of two routes.
  • Inside an approved device study
  • No history of prostate or bladder cancer, a prostate larger than 80 grams, and not a candidate for surgery

Covered with conditions: The insurer's written policy covers it only when the listed conditions are met.

Checked November 7, 2026 · Benign Prostatic Hyperplasia Treatments (HUM-1021-010) · In effect September 1, 2026

HCSC (Blue Cross in Illinois, Texas, Montana, New Mexico, and Oklahoma)

No specific policyHCSC's pelvic embolization policy no longer addresses this procedure.

It had been listed as investigational since May 2021, and that statement was removed on January 1, 2026. We found no separate policy. Ask your plan.

No specific policy: We found no written policy. That does not mean it is covered, and it does not mean it is not covered.

Checked November 7, 2026 · Therapeutic Embolization and Vessel Occlusion to Treat Pelvic Conditions (SUR701.015) · In effect January 1, 2026

Ambetter (Centene)

No specific policyWe found no Ambetter or Centene policy on this procedure in Ambetter's Florida list or in web searches.

Ambetter says it uses a licensed tool (InterQual) that is not public when it has no policy of its own. No policy does not mean covered or not covered. Ask your plan.

No specific policy: We found no written policy. That does not mean it is covered, and it does not mean it is not covered.

Checked November 7, 2026 · Ambetter clinical policy list (Florida)

Molina

No specific policyWe found no Molina policy on this procedure in a web search.

We could not open Molina's full policy list, so one may exist. Ask your plan.

No specific policy: We found no written policy. That does not mean it is covered, and it does not mean it is not covered.

Checked November 7, 2026 · Molina clinical policies

Kaiser Permanente

Not coveredKaiser's Washington region says there is not enough evidence. It covers this procedure only inside an approved device study, for Medicare members. We found no public criteria for other regions we searched, and we did not search every region. Ask your plan.

Not covered: The written policy calls it not covered, experimental, investigational, or unproven.

Checked November 7, 2026 · Benign Prostatic Hyperplasia Treatments (Kaiser Permanente Washington) · Latest dated change November 4, 2025

Medicaid, or your insurer is not listed? We did not check Medicaid or every insurer. Call the number on your insurance card and ask: Questions to ask your plan

Questions to ask your plan

What if my insurer says no?

This is general information. Your doctor's office and your plan can tell you what applies to you. Your denial letter lists your own deadlines.

Prior authorization: approval before the procedure

Some plans want to approve a procedure before you have it. This is called prior authorization or preauthorization. An approval is not a promise that the plan will pay.1

Appeal: ask your plan to look again

If your plan says no, you can ask it for a full review of its decision. This is called an internal appeal.2 For most plans, you have 180 days from the denial notice to file, and for a procedure you have not had yet, the plan must decide within 30 days.3 Some older plans follow different rules.4

Peer-to-peer call: your doctor talks with the insurer

Your doctor may be able to talk with a reviewer at your insurer about why you need the procedure. This is called a peer-to-peer call, and it can be used to seek approval or to appeal a denial.5 Ask your doctor's office whether it can request one.

External review: an independent decision

If your appeal fails, you can ask an independent reviewer to decide. External review covers denials that involve medical judgment, and denials that call a treatment experimental or investigational. You must ask in writing within 4 months of the final denial. Your insurer has to accept the decision. It costs nothing or at most $25, depending on the process your insurer uses.6 In urgent cases, you can ask before your appeal is finished.3 Employer plans that pay their own claims may use a state process or a federal one.4

If you have Original Medicare

Before a service, your doctor's office may give you an Advance Beneficiary Notice. It tells you that Medicare may not pay. You choose one of three options, and the office cannot choose for you. If you have the service and ask the office to bill Medicare, you accept the cost if Medicare does not pay, and you keep your right to appeal. The other two options end with no claim and no appeal.7 Your Medicare Summary Notice gives the date to file an appeal, which is called a redetermination.8

If you have a Medicare Advantage plan

These plans must cover what Original Medicare covers and follow Medicare's coverage decisions. Where Medicare's rules are not fully set, a plan can write its own public rules.9 To appeal, follow the directions in your denial notice within 65 days of its date. Your doctor can ask for you if you have not had the procedure yet.10

A clinical trial

Some insurers cover a procedure inside an approved study; see the insurer cards above. Medicare covers the routine costs of qualifying trials. The item being studied is not a routine cost, but Medicare can separately cover a device in an approved device study.11 Ask the study team what you would pay. You can search for studies at ClinicalTrials.gov.

Paying yourself

If you do not use insurance, you can ask for a written good faith estimate of the cost. The office must give you one if you ask, or if you schedule at least 3 business days ahead. If your bill is at least $400 above that estimate, you may be able to dispute it. You must start within 120 days of the date on the original bill.12

Next steps

Sources (12)

  1. HealthCare.gov. Glossary: Preauthorization. Read 2026-11-08. https://www.healthcare.gov/glossary/preauthorization
  2. HealthCare.gov. How to appeal an insurance company decision. Read 2026-11-08. https://www.healthcare.gov/appeal-insurance-company-decision/appeals/
  3. HealthCare.gov. Internal appeals. Read 2026-11-08. https://www.healthcare.gov/how-do-i-appeal-a-health-insurance-companys-decision/internal-appeals/
  4. 45 CFR 147.136, Internal claims and appeals and external review processes, paragraphs (a)(1)(ii) and (c)(1)(ii). Read 2026-11-08. https://www.law.cornell.edu/cfr/text/45/147.136
  5. American Medical Association. Fixing prior auth: Give doctors a true peer to talk with, stat. April 24, 2025. Read 2026-11-08. https://www.ama-assn.org/practice-management/prior-authorization/fixing-prior-auth-give-doctors-true-peer-talk-stat
  6. HealthCare.gov. External review. Read 2026-11-08. https://www.healthcare.gov/how-do-i-appeal-a-health-insurance-companys-decision/external-review/
  7. CMS Medicare Learning Network. Advance Beneficiary Notice of Noncoverage interactive tutorial, text version. Read 2026-11-08. https://cms.gov/files/document/advance-beneficiary-notice-noncoverage-interactive-tutorial-text-only-2pdf
  8. Medicare.gov. Appeals in Original Medicare. Read 2026-11-08. https://www.medicare.gov/providers-services/claims-appeals-complaints/appeals/original-medicare
  9. 42 CFR 422.101, Requirements relating to basic benefits, paragraphs (a), (b), and (b)(6). Read 2026-11-08. https://www.law.cornell.edu/cfr/text/42/422.101
  10. Medicare.gov. Appeals in Medicare health plans. Read 2026-11-08. https://www.medicare.gov/providers-services/claims-appeals-complaints/appeals/medicare-health-plans
  11. CMS. National Coverage Determination 310.1, Routine Costs in Clinical Trials. Read 2026-11-08. https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=1
  12. CMS. Understanding the Good Faith Estimate and Patient-Provider Dispute Resolution Process. February 2022. Read 2026-11-08. https://www.cms.gov/marketplace/technical-assistance-resources/understanding-good-faith-estimate-and-dispute-resolution-process.pdf

Page last reviewed November 8, 2026.